NASDAQ:BLRX   BioLineRx Ltd.
BLRX looks to test 200MA on continuation

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.